Managing GERD in Patients Taking Ozempic (Semaglutide)

Initial Treatment Approach

The American Gastroenterological Association recommends starting with a proton pump inhibitor (PPI) at standard once-daily dosing for 4-8 weeks as first-line therapy for typical GERD symptoms in patients taking Ozempic, with an initial dose of omeprazole 20 mg once daily or equivalent PPI 1, 2
If symptoms persist after 4-8 weeks of once-daily PPI therapy, escalate to twice-daily dosing before the morning and evening meals, as supported by expert consensus despite most clinical trial data being from once-daily studies 2, 3, 4
Patients who fail to respond to twice-daily PPI therapy after 8 weeks should be considered treatment failures and require further diagnostic evaluation with endoscopy 2, 3, 4, 1

Perform endoscopy to evaluate for alternative diagnoses, complications, or to confirm GERD diagnosis if symptoms persist despite twice-daily PPI 2, 3, 4, 1
Consider switching to a different PPI if side effects are problematic, as individual responses vary 2, 4
Add alginate-antacid preparations to PPI therapy for additional symptom control, particularly for postprandial symptoms 5
Avoid adding H2-receptor antagonists at night to twice-daily PPI therapy, as there is no evidence of improved efficacy with this combination 2, 3, 4

Recommend targeted lifestyle changes based on specific symptom triggers, including elevating the head of the bed by 6-8 inches for patients with nighttime symptoms 1
Encourage weight loss in overweight or obese patients, as this has a dose-dependent association with GERD symptom reduction 5, 1
Avoid specific trigger foods only if they consistently provoke symptoms in the individual patient 1

After symptom resolution, taper PPI to the lowest effective dose that maintains symptom control, which may be once-daily dosing or even on-demand therapy for non-erosive GERD 1
Chronic PPI therapy is appropriate for patients requiring ongoing symptom control, with generally minimal safety concerns, although slight increases in C. difficile colitis and bacterial gastroenteritis are possible 1
For patients requiring long-term PPI therapy (>12 months), consider objective reflux testing with endoscopy and pH monitoring to confirm the GERD diagnosis 1

Do not use metoclopramide as monotherapy or adjunctive therapy, as it is not recommended for GERD management 3
Do not discontinue Ozempic prematurely for GERD symptoms without first attempting adequate PPI therapy, as the metabolic benefits of semaglutide often outweigh manageable reflux symptoms 1
Ensure adequate PPI dosing and duration before declaring treatment failure, as inadequate dosing is a common cause of apparent PPI-refractory GERD 6